Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
European Urology|October 10, 2019
Response of Primary Renal Cell Carcinoma to Systemic TherapyDominick Bossé, Xun Lin, Ronit Simantov, et al.
Journal for Immunotherapy of Cancer|August 16, 2017
Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case seriesDylan J Martini, Aly-Khan A Lalani, Dominick Bossé, et al.
Cancer|March 9, 2026
Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agentsTzu-Fei Wang, Anna Clarke, Mitchell Rath, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 27, 2022
A survey of physician perception and practices regarding pharmacological thromboprophylaxis during chemotherapy for bladder cancerAndrew Amenyogbe, Francis Lemire, David Yachnin, et al.
Nature Communications|August 5, 2017
Pan-urologic cancer genomic subtypes that transcend tissue of originFengju Chen, Yiqun Zhang, Dominick Bossé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2018
Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma with Bone MetastasesRana R McKay, Dominick Bossé, Kathryn P Gray, et al.
Cancer Immunology Research|March 2, 2017
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer PatientsGuillermo De Velasco, Youjin Je, Dominick Bossé, et al.
Cancers|January 25, 2025
Diagnosis and Management of Skin Toxicities in Systemic Treatment of Genitourinary CancersDeepro Chowdhury, Laura Chin, Roupen Odabashian, et al.
Clinical Genitourinary Cancer|September 3, 2017
Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant MetastasisElena Sevillano, Lillian Werner, Dominick Bossé, et al.
British Journal of Cancer|September 18, 2018
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinomaJoaquim Bellmunt, Aly-Khan A Lalani, Sussana Jacobus, et al.
Pageof 5